FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897721472> ?p ?o ?g. }

• W2897721472 abstract "To reduce treatment variability and facilitate comparative effectiveness studies, the Childhood Arthritis and Rheumatology Research Alliance (CARRA) published consensus treatment plans (CTPs) including one for juvenile proliferative lupus nephritis (LN). Induction immunosuppression CTPs outline treatment with either monthly intravenous (IV) cyclophosphamide (CYC) or mycophenolate mofetil (MMF) in conjunction with one of three corticosteroid (steroid) CTPs: primarily oral, primarily IV or mixed oral/IV. The acceptability and in-practice use of these CTPs are unknown. Therefore, the primary aims of the pilot study were to demonstrate feasibility of adhering to the LN CTPs and delineate barriers to implementation in clinical care in the US. Further, we aimed to explore the safety and effectiveness of the treatments for induction therapy. Forty-one patients were enrolled from 10 CARRA sites. Patients had new-onset biopsy proven ISN/RPS class III or IV proliferative LN, were starting induction therapy with MMF or IV CYC and high-dose steroids and were followed for up to 24 months. Routine clinical data were collected at each visit. Provider reasons for CTP selection were assessed at baseline. Adherence to the CTPs was evaluated by provider survey and medication logs. Complete and partial renal responses were reported at 6 months. The majority of patients were female (83%) with a mean age of 14.7 years, SD 2.8. CYC was used more commonly than MMF for patients with ISN/RPS class IV LN (vs. class III), those who had hematuria, and those with adherence concerns. Overall adherence to the immunosuppression induction CTPs was acceptable with a majority of patients receiving the target MMF (86%) or CYC (63%) dose. However, adherence to the steroid CTPs was poor (37%) with large variability in dosing. Renal response endpoints were exploratory and did not show a significant difference between CYC and MMF. Overall, the immunosuppression CTPs were followed as intended in the majority of patients however, adherence to the steroid CTPs was poor indicating revision is necessary. In addition, our pilot study revealed several sources of treatment selection bias that will need to be addressed in for future comparative effectiveness research." @default.
• W2897721472 created "2018-10-26" @default.
• W2897721472 creator A5000390332 @default.
• W2897721472 creator A5005158159 @default.
• W2897721472 creator A5011195506 @default.
• W2897721472 creator A5012083798 @default.
• W2897721472 creator A5016731880 @default.
• W2897721472 creator A5020607453 @default.
• W2897721472 creator A5021386589 @default.
• W2897721472 creator A5029378975 @default.
• W2897721472 creator A5030180190 @default.
• W2897721472 creator A5036186800 @default.
• W2897721472 creator A5038521422 @default.
• W2897721472 creator A5055340634 @default.
• W2897721472 creator A5057881013 @default.
• W2897721472 creator A5059855682 @default.
• W2897721472 creator A5082669927 @default.
• W2897721472 creator A5090678049 @default.
• W2897721472 date "2018-10-22" @default.
• W2897721472 modified "2023-09-26" @default.
• W2897721472 title "Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis" @default.
• W2897721472 cites W1958084401 @default.
• W2897721472 cites W2036335844 @default.
• W2897721472 cites W2068121948 @default.
• W2897721472 cites W2070527591 @default.
• W2897721472 cites W2072962516 @default.
• W2897721472 cites W2094752814 @default.
• W2897721472 cites W2097773466 @default.
• W2897721472 cites W2098488998 @default.
• W2897721472 cites W2110793425 @default.
• W2897721472 cites W2134348333 @default.
• W2897721472 cites W2138889351 @default.
• W2897721472 cites W2149459259 @default.
• W2897721472 cites W2151072497 @default.
• W2897721472 cites W2152073293 @default.
• W2897721472 cites W2161335088 @default.
• W2897721472 cites W2171121999 @default.
• W2897721472 cites W2298285162 @default.
• W2897721472 cites W2409438019 @default.
• W2897721472 cites W2589667046 @default.
• W2897721472 cites W2613529089 @default.
• W2897721472 cites W4251458288 @default.
• W2897721472 doi "https://doi.org/10.1186/s12969-018-0279-0" @default.
• W2897721472 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6196456" @default.
• W2897721472 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30348175" @default.
• W2897721472 hasPublicationYear "2018" @default.
• W2897721472 type Work @default.
• W2897721472 sameAs 2897721472 @default.
• W2897721472 citedByCount "15" @default.
• W2897721472 countsByYear W28977214722019 @default.
• W2897721472 countsByYear W28977214722020 @default.
• W2897721472 countsByYear W28977214722021 @default.
• W2897721472 countsByYear W28977214722022 @default.
• W2897721472 countsByYear W28977214722023 @default.
• W2897721472 crossrefType "journal-article" @default.
• W2897721472 hasAuthorship W2897721472A5000390332 @default.
• W2897721472 hasAuthorship W2897721472A5005158159 @default.
• W2897721472 hasAuthorship W2897721472A5011195506 @default.
• W2897721472 hasAuthorship W2897721472A5012083798 @default.
• W2897721472 hasAuthorship W2897721472A5016731880 @default.
• W2897721472 hasAuthorship W2897721472A5020607453 @default.
• W2897721472 hasAuthorship W2897721472A5021386589 @default.
• W2897721472 hasAuthorship W2897721472A5029378975 @default.
• W2897721472 hasAuthorship W2897721472A5030180190 @default.
• W2897721472 hasAuthorship W2897721472A5036186800 @default.
• W2897721472 hasAuthorship W2897721472A5038521422 @default.
• W2897721472 hasAuthorship W2897721472A5055340634 @default.
• W2897721472 hasAuthorship W2897721472A5057881013 @default.
• W2897721472 hasAuthorship W2897721472A5059855682 @default.
• W2897721472 hasAuthorship W2897721472A5082669927 @default.
• W2897721472 hasAuthorship W2897721472A5090678049 @default.
• W2897721472 hasBestOaLocation W28977214721 @default.
• W2897721472 hasConcept C126322002 @default.
• W2897721472 hasConcept C198451711 @default.
• W2897721472 hasConcept C2776694085 @default.
• W2897721472 hasConcept C2776755627 @default.
• W2897721472 hasConcept C2776912625 @default.
• W2897721472 hasConcept C2777077863 @default.
• W2897721472 hasConcept C2779134260 @default.
• W2897721472 hasConcept C2779912601 @default.
• W2897721472 hasConcept C2780252810 @default.
• W2897721472 hasConcept C2991767035 @default.
• W2897721472 hasConcept C71924100 @default.
• W2897721472 hasConceptScore W2897721472C126322002 @default.
• W2897721472 hasConceptScore W2897721472C198451711 @default.
• W2897721472 hasConceptScore W2897721472C2776694085 @default.
• W2897721472 hasConceptScore W2897721472C2776755627 @default.
• W2897721472 hasConceptScore W2897721472C2776912625 @default.
• W2897721472 hasConceptScore W2897721472C2777077863 @default.
• W2897721472 hasConceptScore W2897721472C2779134260 @default.
• W2897721472 hasConceptScore W2897721472C2779912601 @default.
• W2897721472 hasConceptScore W2897721472C2780252810 @default.
• W2897721472 hasConceptScore W2897721472C2991767035 @default.
• W2897721472 hasConceptScore W2897721472C71924100 @default.
• W2897721472 hasFunder F4320306237 @default.
• W2897721472 hasFunder F4320306998 @default.
• W2897721472 hasIssue "1" @default.
• W2897721472 hasLocation W28977214721 @default.
• W2897721472 hasLocation W28977214722 @default.
• W2897721472 hasLocation W28977214723 @default.

• next